Quintiles

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

Quintiles to offer jobs to 100 Merck Serono employees affected by cuts

Wednesday, June 27, 2012 10:16 AM

CRO Quintiles has committed to make at least 100 employment offers within the next three months to Merck Serono employees primarily working in global development and medical function in Geneva.

More... »

Quintiles deepens investment in China

Monday, June 18, 2012 09:34 AM

Quintiles has decided to establish a Quintiles regional headquarters for China in Shanghai and to significantly expand lab testing capabilities in China.

More... »

Quintiles names Tom Pike CEO

Monday, April 23, 2012 10:01 AM

Quintiles, a global biopharmaceutical services company, has appointed Tom Pike as CEO effective April 30 as part of the company’s long-term succession planning. 

More... »

Quintiles named best CRO in vaccine excellence awards

Friday, April 13, 2012 02:01 PM

Quintiles, a global biopharmaceutical services company, has been named “Best Clinical Research Organization” (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012, which recognizes and celebrates the leaders, innovators and pioneers in the vaccines industry.

More... »

Quintiles to incorporate Archimedes’ healthcare simulator

Friday, March 30, 2012 02:19 PM

Quintiles and Archimedes, a healthcare modeling organization based in San Francisco, Calif., have formed an agreement to co-promote clinical and commercial solutions for biopharmaceutical companies to help reduce the time and expense associated with developing and marketing novel therapies.

More... »

Delcath selects Quintiles to support EU launch of Chemosat

Wednesday, March 14, 2012 04:47 PM

Delcath Systems, an ongology-focused pharmaceutical company, has selected Quintiles to provide a specialized team of Medical Science Liaisons (MSLs) to support the launch of the Hepatic Chemosat Delivery System for the treatment of cancers in the liver in France, Germany, Italy, Netherlands, Spain, Ireland and the U.K. 

More... »

Quintiles and RCV Biofund to expand clinical development capabilities in Russia

Monday, February 27, 2012 09:56 AM

Quintiles and Russian Venture Company (RVC) Biofund, a Russian-based investment firm, have joined to support expansion of clinical development services within the Russian Federation, the world's ninth most populous country.

More... »

Quintiles launches strategic drug development and consulting services in Asia

Tuesday, February 14, 2012 11:52 AM

To help biopharmaceutical companies navigate the complexities of the Asia market, Quintiles has launched two services—Strategic Drug Development and Consulting at Quintiles—to bolster the probability of success in developing and commercializing new medications in the region.

More... »

Quintiles expands commercial services in Middle East and North Africa

Tuesday, February 14, 2012 11:42 AM

Quintiles is extending its global footprint to provide commercial services in the Middle East and North Africa (MENA) region through an agreement with Dayarn Pharma, a United Arab Emirates (UAE)-based company that specializes in biopharmaceutical sales, marketing and regulatory efforts needed to maximize brands in the Arab Gulf region.

More... »